Biotech analysts see plunge as buying opportunity By: MarketWatch August 12, 2011 at 14:35 PM EDT While most investors fled for safer havens this week, biotech analysts were advising clients to take advantage of discounted stock prices. Read More >> Related Stocks: Illumina Inc Standard & Poors 500 Vertex Pharmaceuticals